{"name":"Sihuan Pharmaceutical","slug":"sihuan","ticker":"0460","exchange":"HKEX","domain":"sfrx.com.cn","description":"Sihuan Pharmaceutical is a Chinese pharmaceutical manufacturer with headquarters in Beijing and branch office in Haikou, Hainan Province. The main company in the group is the holding company Sihuan Pharmaceutical Holdings Group Ltd, which is listed on the Hong Kong stock market.","hq":"Beijing, China","founded":0,"employees":"2843","ceo":"Che Fengsheng","sector":"Cardiovascular / CNS / Specialty Pharma","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":1.15,"stockChange":0.05,"stockChangePercent":4.55,"marketCap":"$1.5B","metrics":{"revenue":385846662.34659326,"revenueGrowth":54.7,"grossMargin":68.8,"rdSpend":0,"netIncome":26483914.54192,"cash":586179584.8883942,"dividendYield":1.98,"peRatio":57.5,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"Unknown patent cliff ($100M at risk)","drug":"Unknown","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"oncology","drugs":[{"name":"Levophencynonate Hydrochloric","genericName":"Levophencynonate Hydrochloric","slug":"levophencynonate-hydrochloric","indication":"Other","status":"phase_2"},{"name":"Anaprazole Sodium enteric-coated tablet","genericName":"Anaprazole Sodium enteric-coated tablet","slug":"anaprazole-sodium-enteric-coated-tablet","indication":"Other","status":"marketed"},{"name":"Banapenem","genericName":"Banapenem","slug":"banapenem","indication":"Other","status":"phase_1"},{"name":"Fadanafil","genericName":"Fadanafil","slug":"fadanafil","indication":"Other","status":"phase_1"},{"name":"KBP-5209","genericName":"KBP-5209","slug":"kbp-5209","indication":"Other","status":"phase_1"},{"name":"XZP-3287","genericName":"XZP-3287","slug":"xzp-3287","indication":"Other","status":"phase_1"},{"name":"XZP-3287;Letrozole;Anastrozole;Fulvestrant","genericName":"XZP-3287;Letrozole;Anastrozole;Fulvestrant","slug":"xzp-3287-letrozole-anastrozole-fulvestrant","indication":"Other","status":"phase_1"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Placebo/Janagliflozin","genericName":"Placebo/Janagliflozin","slug":"placebo-janagliflozin","indication":"Type 2 diabetes mellitus","status":"phase_3"},{"name":"Janagliflozin plus metformin","genericName":"Janagliflozin plus metformin","slug":"janagliflozin-plus-metformin","indication":"Type 2 diabetes mellitus","status":"phase_3"}]}],"pipeline":[{"name":"Levophencynonate Hydrochloric","genericName":"Levophencynonate Hydrochloric","slug":"levophencynonate-hydrochloric","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Placebo/Janagliflozin","genericName":"Placebo/Janagliflozin","slug":"placebo-janagliflozin","phase":"phase_3","mechanism":"Janagliflozin is an SGLT2 inhibitor that blocks glucose reabsorption in the kidney, promoting urinary glucose excretion and lowering blood glucose levels.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"Anaprazole Sodium enteric-coated tablet","genericName":"Anaprazole Sodium enteric-coated tablet","slug":"anaprazole-sodium-enteric-coated-tablet","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Banapenem","genericName":"Banapenem","slug":"banapenem","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Fadanafil","genericName":"Fadanafil","slug":"fadanafil","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Janagliflozin plus metformin","genericName":"Janagliflozin plus metformin","slug":"janagliflozin-plus-metformin","phase":"phase_3","mechanism":"Janagliflozin is an SGLT2 inhibitor that reduces blood glucose by blocking renal glucose reabsorption, combined with metformin which decreases hepatic glucose production and improves insulin sensitivity.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"KBP-5209","genericName":"KBP-5209","slug":"kbp-5209","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"XZP-3287","genericName":"XZP-3287","slug":"xzp-3287","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"XZP-3287;Letrozole;Anastrozole;Fulvestrant","genericName":"XZP-3287;Letrozole;Anastrozole;Fulvestrant","slug":"xzp-3287-letrozole-anastrozole-fulvestrant","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[{"date":"2023-09-28","type":"regulatory","headline":"Sihuan Pharmaceutical Receives Approval for New Drug in China","summary":"Sihuan Pharmaceutical announced that it has received approval from the National Medical Products Administration (NMPA) for a new drug in China.","drugName":"Unknown","sentiment":"positive"},{"date":"2022-03-31","type":"earnings","headline":"Sihuan Pharmaceutical Reports 2021 Annual Results","summary":"Sihuan Pharmaceutical reported its 2021 annual results, with revenue increasing by 10% year-over-year.","drugName":"Unknown","sentiment":"neutral"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPTkRYdEtBV2IySFhlNzJHbzdSOXV3RHNsamk3OTgzZ0RIZGo4dWdxR21BVEF5MEQ0bFU4YW5JTHN4MXRTQjlHM2JpU3JzTlhiTXY3bmZkMTRsbFQ0Y2lRT1k4eVctWHhMakFZdm1OcTctUFExcDFDZHhPNGt6bWE4N21SZ2tFVjUtQkQ5dS15eXgwZkRrTjdZNEZQSEg5X256VkhVSUFWWC0ySUxURUJ6SEdjRENGYUk?oc=5","date":"2026-04-01","type":"pipeline","source":"TipRanks","summary":"Sihuan Pharma Teams With Biocytogen on AI-Driven Obesity Drug R&D - TipRanks","headline":"Sihuan Pharma Teams With Biocytogen on AI-Driven Obesity Drug R&D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQVzRLLUpLSno3V3NDN1daenhScXhEM05aSGtnSWt6UG9CVXk2ZlAzY3lfOFoxRzNhYU9GcU5KOEdhMklteWp5dXJjOWloX1NUR3FfR3lQS1lxU3AwbFBkWE1uTXo1NEZNMUpPbTNTWThkZ2NSZVlNZS0wVk03MG5qdVZlVHhPNkxHMVBDdVpoSTVGQUpfZk1vQnBwbnc1UTY0UGhGV2dZR21LbHhFTlhGb09GN0g0ejlRNUJRNTYtWXFwX3VNc09OZg?oc=5","date":"2026-03-31","type":"earnings","source":"TipRanks","summary":"Sihuan Pharmaceutical’s Medical Aesthetics Push Lifts 2025 Revenue and Margins - TipRanks","headline":"Sihuan Pharmaceutical’s Medical Aesthetics Push Lifts 2025 Revenue and Margins","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxObUpqU3VJT2FSWEJ0YUpoelZnenV3R0VDSTdiOHdBNGMyQU85c3V3a0lrUTljUUhUZ0xiM00xUFZEUVJxTng4QlE1T2hsVDRGbU9vcm9WUm13NE02QzFueFJ3b05YMzlwZ1FfamFrQ3Z3d1RkODJlLTQ1VjN4djhrYzRtbXozLTE0RTlCZ0dGQjVXd0tmRWtXY3VKUHAxZzJJN3JBMzE5VEZLOERsOTFMa1ZGaXNVbmtPdU01bFMzMDd1QQ?oc=5","date":"2026-03-30","type":"earnings","source":"TipRanks","summary":"Sihuan Pharma Subsidiary Xuanzhu Narrows Loss as Revenue Doubles in 2025 - TipRanks","headline":"Sihuan Pharma Subsidiary Xuanzhu Narrows Loss as Revenue Doubles in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxOdE5NX1ktUmkwcGhIa21YWlJMS1loeVVVMjBXX3NETUN6M3NqWDFKemN6MnNJRjE2ZmE3RVVEQlZIZ0Vvb3hYMFMwU1pEVnY0Y2d4cmlfTWRRTjY1ZG1yNEVDRUZoXzdNaERRb29ucnppM19GdFVRalhaRjFPVm4ya25EOF94cG9rcWdzNFZtcUpPUVdoUkh1QUpZMExWV1FoXzZWcXdHMzEyeVdVVFNId3ZiUlZEbC1jVUZ3VXdjdy1fV2dIVG14WkhtX0oxTWpXNEdMRWhjM09NclFkaHhuTVN6Z3pkTUMzWk5yMlJUQmNoWHFv?oc=5","date":"2026-03-08","type":"pipeline","source":"Minichart","summary":"Xuanzhu Biopharm Shares Included in Hong Kong Stock Connect, Boosting Sihuan Pharmaceutical’s Market Value and Liquidity 12 - Minichart","headline":"Xuanzhu Biopharm Shares Included in Hong Kong Stock Connect, Boosting Sihuan Pharmaceutical’s Market Value and Liquidity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxORmlhY0RLUjIzRlVtX2V5dkFwaDhFNGhBV1hfQmhBSV8yRFpiNEU0SmwtWVBLal9MQmtQVUJ1TEVxUG40eUdKdEQxMFBGMGE2NGhVSGg4aS10czBNV1pSamRiN1hpZGNCWjc3cVd5SV9pYk41QVpEVllsYkJqRG9NNHF3Sjk1S21EaWRDZ3pYV094ejNqNi1OUWxEWGUyQ3A3d3VDQkdoZU9qV2hGdjc5TXpkTGlZUkk5NVd5eGFTSG1LQ2psM0hpdHBvWF9tLW15X0RjUkVOVVplekhLMkUwTHh0Q211U3c?oc=5","date":"2026-02-22","type":"pipeline","source":"Minichart","summary":"Xuanzhu Biopharm Added to Hang Seng Composite Index, Boosting Sihuan Pharmaceutical’s Innovative Drug Profile 123 - Minichart","headline":"Xuanzhu Biopharm Added to Hang Seng Composite Index, Boosting Sihuan Pharmaceutical’s Innovative Drug Profile 123","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQLXBiSWhQb3FPNHlfRUlYejBhYlpTOU1Hb2FsckpkVjBBQkU2RkUwN2FtLVRyNE1COExWYlYySkd1dHFudzJOSkppSjlHZS1WRHJCX3JhWTFHcUJtczBJWERPRWR0RE1DVFMzUHNwQzdWNXlCNHMwS04yWWItQkU3Q0VTZmNpVjhtX2owbjlRbnZaMzh3aS12cUNIRGRrM1d5Xy1DaGl3TFFncHc?oc=5","date":"2025-10-16","type":"pipeline","source":"The Pharma Letter","summary":"Xuanzhu Bio raises $100 million in oversubscribed Hong Kong IPO - The Pharma Letter","headline":"Xuanzhu Bio raises $100 million in oversubscribed Hong Kong IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQWnBvT21RR3AxVHRTeWducGNOd1QyaFdiUUE4VUxuRWxIdkdLUnRmLTkyY1JVdGZZUUxqU2l0UmhoU1dDOW4yWDRoZ3B3N1QwblgzS2JBUkkyOUo0T1BnSFB0OWRrMHd6Z1dvdEF6RVhiRU1TcW45akZsNVc5T2EyNFhuaGk?oc=5","date":"2024-12-05","type":"pipeline","source":"thebambooworks.com","summary":"Xuanzhu Biopharm set for spin-off in Hong Kong IPO - thebambooworks.com","headline":"Xuanzhu Biopharm set for spin-off in Hong Kong IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQZl9rS2ZRVFNWUzNqNmZ6UUNVYW1ZTE4zRFlUcGJxZHhnV2h6M05ySVQ5c1J3eWVLVEZNR3V1aHRaUjZNOUd2a2VNZDYtRjVCRkZkMkNjcnpMT3Y0dlRRV01iUGdZWUhtYWktQlVTTzJGUUlWWHVzSHA2OGNvQ0VjYW5ybWl3SWJEM3hIUFFjWFBWMUJMc1hPeVdGY1JFMGc2dnc?oc=5","date":"2024-10-07","type":"deal","source":"thebambooworks.com","summary":"FAST NEWS: Sihuan Pharma stock skyrockets on latest share buyback program - thebambooworks.com","headline":"FAST NEWS: Sihuan Pharma stock skyrockets on latest share buyback program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOQlpsaFE1aW5td2FCSmVJZHBYSGhCQTFwNmY0eUVjZUJwcjR1VVNOZ04ySWUzRkhfTjh1VkNseFdMS2FGVTdYS2c3YXY5SlRQRkt5ZENMa2dKckl0ZWtFMmw4d1JaRTRuUWc4TnVuNWMzQnRQOFJoT1RVZkxYNU1SWFhtVDFnUWIwUDhUdDhCc0RWODJYZGo3SWtlU29KZXhyakFHUl9FcUMzQUh0UXVnM0paV1dkenpNakZua3JOZmRGOWpTS3RtYm40dU0wM09xN1Nka2lmdG9renpZ?oc=5","date":"2022-05-12","type":"pipeline","source":"Reuters","summary":"China Resources in talks to take Sihuan Pharma private at $3 bln valuation -sources - Reuters","headline":"China Resources in talks to take Sihuan Pharma private at $3 bln valuation -sources","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE5TQzFsQ1NTcGw1Smc2VTlRRm9OUFhmcHIwSTBERnA3ZFdPRDRDdzZRRkVBWWpmUmxzXzNsdktJV0Q1VmlVSXUyXzd4UVFwOEZQaUpTUC1n?oc=5","date":"2017-06-11","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) stock price, news, quote and history","sentiment":"neutral"}],"patents":[{"drugName":"Unknown","drugSlug":"unknown","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"China","annualRevenue":100000000}],"drugCount":9,"phaseCounts":{"phase_2":1,"phase_3":2,"marketed":1,"phase_1":5},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["BeiGene","Innovent Biologics","Hengrui Pharmaceutical"],"therapeuticFocus":["Cardiovascular","CNS"],"financials":{"source":"yahoo_finance","revenue":385846652.91416,"revenuePeriod":"2025-12-31","revenueHistory":[{"period":"2025-12-31","value":385846652.91416},{"period":"2024-12-31","value":280188809.38293},{"period":"2023-12-31","value":274209530.97403},{"period":"2022-12-31","value":321467495.52453}],"grossProfit":265561021.32865998,"grossProfitHistory":[{"period":"2025-12-31","value":265561021.32865998},{"period":"2024-12-31","value":183005417.62669998},{"period":"2023-12-31","value":190954306.00988},{"period":"2022-12-31","value":219242320.79837}],"rdSpend":42928477.67498,"rdSpendHistory":[{"period":"2025-12-31","value":42928477.67498},{"period":"2024-12-31","value":69847905.34725},{"period":"2023-12-31","value":85135963.73111999},{"period":"2022-12-31","value":138034965.52837}],"sgaSpend":164788588.70938998,"operatingIncome":55281870.254609995,"operatingIncomeHistory":[{"period":"2025-12-31","value":55281870.254609995},{"period":"2024-12-31","value":-68074902.65415},{"period":"2023-12-31","value":-28221398.22845},{"period":"2022-12-31","value":-81680155.98816}],"netIncome":26483914.54192,"netIncomeHistory":[{"period":"2025-12-31","value":26483914.54192},{"period":"2024-12-31","value":-31932029.05174},{"period":"2023-12-31","value":-7961121.07009},{"period":"2022-12-31","value":-282224004.24486}],"eps":0.0197,"epsHistory":[{"period":"2025-12-31","value":0.0197},{"period":"2024-12-31","value":-0.0234},{"period":"2023-12-31","value":-0.0058},{"period":"2022-12-31","value":-0.2052}],"cash":524753676.37562,"cashHistory":[{"period":"2025-12-31","value":524753676.37562},{"period":"2024-12-31","value":519135041.15791},{"period":"2023-12-31","value":556906483.31882},{"period":"2022-12-31","value":590420803.05328}],"totalAssets":1714334284.53433,"totalLiabilities":697367352.78139,"totalDebt":148365395.93298,"equity":862105389.5436699,"operatingCashflow":-3472461.8829699997,"operatingCashflowHistory":[{"period":"2025-12-31","value":-3472461.8829699997},{"period":"2024-12-31","value":40698149.34957},{"period":"2023-12-31","value":29400747.15199},{"period":"2022-12-31","value":6852220.63261}],"capex":-28665901.64677,"capexHistory":[{"period":"2025-12-31","value":-28665901.64677},{"period":"2024-12-31","value":-27468277.38375},{"period":"2023-12-31","value":-43539227.72986},{"period":"2022-12-31","value":-87535486.32849}],"freeCashflow":-32138363.52974,"dividendsPaid":-13395086.92999,"buybacks":-27799886.36625,"employees":2843,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":1.15,"previousClose":1.1,"fiftyTwoWeekHigh":1.92,"fiftyTwoWeekLow":0.65,"fiftyTwoWeekRange":"0.65 - 1.92","fiftyDayAverage":1.35,"twoHundredDayAverage":1.44,"beta":0.97,"enterpriseValue":1177747352.9636557,"forwardPE":-57.5,"priceToBook":1.54,"priceToSales":3.97,"enterpriseToRevenue":3.05,"enterpriseToEbitda":12.44,"pegRatio":0,"ebitda":94708553.53722751,"ebitdaMargin":24.5,"freeCashflow":-29061510.86812896,"operatingCashflow":-3472461.8829699997,"totalDebt":143209248.24669248,"debtToEquity":14.1,"currentRatio":1.8,"returnOnAssets":2.7,"returnOnEquity":3.1,"analystRating":"","recommendationKey":"none","numberOfAnalysts":1,"targetMeanPrice":2.01,"targetHighPrice":2.01,"targetLowPrice":2.01,"dividendRate":0.02,"payoutRatio":0.51,"fiveYearAvgDividendYield":2.57,"exDividendDate":1782777600,"insiderHeldPercent":56.2,"institutionHeldPercent":6.9,"sharesOutstanding":9031800206,"floatShares":3709669789,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":0.02,"epsForward":-0.02,"revenuePerShare":0.29,"bookValue":0.75,"officers":[{"age":63,"name":"Dr. Fengsheng  Che","title":"Co-Founder & Executive Chairman"},{"age":61,"name":"Dr. Weicheng  Guo Ph.D.","title":"Deputy Chairman & CEO"},{"age":51,"name":"Ms. Guili  Miao","title":"Deputy CEO, Chief Investment Officer, CFO & Executive Director"},{"age":63,"name":"Dr. Jionglong  Zhang Ph.D.","title":"Executive Director"},{"age":47,"name":"Ms. Yanling  Chen","title":"Joint Company Secretary & Executive Director"},{"age":36,"name":"Mr. Kin Wai  Li","title":"Joint Company Secretary"},{"age":61,"name":"Mr. Xianhui  Meng","title":"Deputy General Manager"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"","website":"https://www.sihuanpharm.com","phone":"852 3628 3911"}}